Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rang în acțiuni #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Preț acțiune
$0.089
Ultima sincronizare: 2026-08-17
Capitalizare de piață
$15.36M
Schimbare (1 zi)
50.59%
Schimbare (1 an)
111.85%
Țară
US
Tranzacționează Inhibitor Therapeutics, Inc. (INTI)

Categorie

Istoric dividende pentru Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. (simbol acțiune: INTI) a efectuat un total de 0 plăți de dividende.
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: 0.00
Randamentul dividendului (TTM): 0
Plăți de dividende pentru Inhibitor Therapeutics, Inc. (INTI) din 2026 până în 2026
Plăți anuale de dividende
An Dividend (ajustat pentru split de acțiuni) Schimbă
Nu sunt suficiente date pentru perioada selectată.
Lista tuturor plăților de dividende
An Dividend Schimbă
Nu sunt suficiente date pentru perioada selectată.
Dividende ale companiilor similare sau concurente
Companie Număr de plăți de dividende Țara
0.00%
US
0.00%
NL
64.00%
AU
0.00%
CH
29.00%
BE